Role of a cdk5-associated protein, p35, in herpes simplex virus type 1 replication in vivo

References

• Advani SJ, Hagglund R, Weichselbaum RR, Roizman B (2001). Posttranslational processing of infected cell proteins 0 and 4 of herpes simplex virus 1 is sequential and reflects the subcellular compartment in which the proteins localize. J Virol 75: 7904–7912.
   PubMed Web of Science ®Google Scholar
• Balliet JW, Schaffer PA (2006). Point mutations in herpes simplex virus type 1 oriL, but not in oriS, reduce pathogenesis during acute infection of mice and impair reactivation from latency. J Virol 80: 440–450.
   PubMed Web of Science ®Google Scholar
• Chae T, Kwon YT, Bronson R, Dikkes P, Li E, Tsai LH (1997). Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 18: 29–42.
   PubMed Web of Science ®Google Scholar
• Coen DM, Kosz-Vnenchak M, Jacobson JG, Leib DA, Bogard CL, Schaffer PA, Tyler KL, Knipe DM (1989). Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc Natl Acad Sci U S A 86: 4736–4740.
   PubMed Web of Science ®Google Scholar
• Davido DJ, Leib DA, Schaffer PA (2002). The cyclin-dependent kinase inhibitor roscovitine inhibits the transactivating activity and alters the posttranslational modification of herpes simplex virus type 1 ICP0. J Virol 76: 1077–1088.
   PubMed Web of Science ®Google Scholar
• Fields BN, Knipe DM, Howley PM (2007). Fields Virology, 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins.
   Google Scholar
• Fu AK, Fu WY, Ng AK, Chien WW, Ng YP, Wang JH, Ip NY (2004). Cyclin-dependent kinase 5 phosphorylates signal transducer and activator of transcription 3 and regulates its transcriptional activity. Proc Natl Acad Sci U S A 101: 6728–6733.
   PubMed Web of Science ®Google Scholar
• Gao C, Negash S, Guo HT, Ledee D, Wang HS, Zelenka P (2002). CDK5 regulates cell adhesion and migration in corneal epithelial cells. Mol Cancer Res 1: 12–24.
   PubMed Web of Science ®Google Scholar
• Gong X, Tang X, Wiedmann M, Wang X, Peng J, Zheng D, Blair LA, Marshall J, Mao Z (2003). Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 38: 33–46.
   PubMed Web of Science ®Google Scholar
• Halford WP, Balliet JW, Gebhardt BM (2004). Re-evaluating natural resistance to herpes simplex virus type 1. J Virol 78: 10086–10095.
   PubMed Web of Science ®Google Scholar
• Halford WP, Schaffer PA (2000). Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants to establish wild-type levels of latency in vivo. J Virol 74: 5957–5967.
   PubMed Web of Science ®Google Scholar
• Ino H, Chiba T (1996). Intracellular localization of cyclin-dependent kinase 5 (CDK5) in mouse neuron: CDK5 is located in both nucleus and cytoplasm. Brain Res 732: 179–185.
   PubMed Web of Science ®Google Scholar
• Jung HW, Jung CR, Choi BK, Vinay DS, Hill JM, Gebhardt BM, Kwon BS (2004). Herpesvirus infection of ICAM-1-deficient mice. Curr Eye Res 29: 201–208.
   PubMed Web of Science ®Google Scholar
• Katz JP, Bodin ET, Coen DM (1990). Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants. J Virol 64: 4288–4295.
   PubMed Web of Science ®Google Scholar
• Ko J, Humbert S, Bronson RT, Takahashi S, Kulkarni AB, Li E, Tsai LH (2001). p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci 21: 6758–6771.
   PubMed Web of Science ®Google Scholar
• Kosz-Vnenchak M, Coen DM, Knipe DM (1990). Restricted expression of herpes simplex virus lytic genes during establishment of latent infection by thymidine kinase-negative mutant viruses. J Virol 64: 5396–5402.
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim HS, Lee SJ, Kim KT (2007). Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death. J Cell Sci 120: 2259–2271.
   PubMed Web of Science ®Google Scholar
• Leib DA, Coen DM, Bogard CL, Hicks KA, Yager DR, Knipe DM, Tyler KL, Schaffer PA (1989). Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virol 63: 759–768.
   PubMed Web of Science ®Google Scholar
• Lew J, Huang QQ, Qi Z, Winkfein RJ, Aebersold R, Hunt T, Wang JH (1994). A brain-specific activator of cyclin-dependent kinase 5. Nature 371: 423–426.
   PubMed Web of Science ®Google Scholar
• Link MA, Schaffer PA (2007). Herpes simplex virus type 1 C-terminal variants of the origin binding protein (OBP), OBPC-1 and OBPC-2, cooperatively regulate viral DNA levels in vitro, and OBPC-2 affects mortality in mice. J Virol 81: 10699–10711.
   PubMed Web of Science ®Google Scholar
• Malumbres M, Barbacid M (2009). Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9: 153–166.
   PubMed Web of Science ®Google Scholar
• National Research Council (1996). Guide for the care and use of laboratory animals. Washington, DC: National Academy Press.
   Google Scholar
• Nikolic M, Chou MM, Lu W, Mayer BJ, Tsai LH (1998). The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature 395: 194–198.
   PubMed Web of Science ®Google Scholar
• Nikolic M, Dudek H, Kwon YT, Ramos YF, Tsai LH (1996). The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev 10: 816–825.
   PubMed Web of Science ®Google Scholar
• Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, Brady RO, Martin LJ, Kulkarni AB (1996). Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci U S A 93: 11173–11178.
   PubMed Web of Science ®Google Scholar
• Qu D, Li Q, Lim HY, Cheung NS, Li R, Wang JH, Qi RZ (2002). The protein SET binds the neuronal Cdk5 activator p35nck5a and modulates Cdk5/p35nck5a activity. J Biol Chem 277: 7324–7332.
   PubMed Web of Science ®Google Scholar
• Rosales JL, Lee KY (2006). Extraneuronal roles of cyclin-dependent kinase 5. Bioessays 28: 1023–1034.
   PubMed Web of Science ®Google Scholar
• Sawtell NM, Thompson RL, Haas RL (2006). Herpes simplex virus DNA synthesis is not a decisive regulatory event in the initiation of lytic viral protein expression in neurons in vivo during primary infection or reactivation from latency. J Virol 80: 38–50.
   PubMed Web of Science ®Google Scholar
• Schaffer PA, Aron GM, Biswal N, Benyesh-Melnick M (1973). Temperature-sensitive mutants of herpes simplex virus type 1: isolation, complementation and partial characterization. Virology 52: 57–71.
   PubMed Web of Science ®Google Scholar
• Schang LM, Bantly A, Schaffer PA (2002). Explant-induced reactivation of herpes simplex virus occurs in neurons expressing nuclear cdk2 and cdk4. J Virol 76: 7724–7735.
   PubMed Web of Science ®Google Scholar
• Schang LM, Phillips J, Schaffer PA (1998). Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription. J Virol 72: 5626–5637.
   PubMed Web of Science ®Google Scholar
• Schang LM, Rosenberg A, Schaffer PA (1999). Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases. J Virol 73: 2161–2172.
   PubMed Web of Science ®Google Scholar
• Schang LM, Rosenberg A, Schaffer PA (2000). Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins. J Virol 74: 2107–2120.
   PubMed Web of Science ®Google Scholar
• Smith DS, Tsai LH (2002). Cdk5 behind the wheel: a role in trafficking and transport? Trends Cell Biol 12: 28–36.
   PubMed Web of Science ®Google Scholar
• Strand SS, Leib DA (2004). Role of the VP16-binding domain of vhs in viral growth, host shutoff activity, and pathogenesis. J Virol 78: 13562–13572.
   PubMed Web of Science ®Google Scholar
• Strelow LI, Leib DA (1995). Role of the virion host shutoff (vhs) of herpes simplex virus type 1 in latency and pathogenesis. J Virol 69: 6779–6786.
   PubMed Web of Science ®Google Scholar
• Tang D, Wang JH (1996). Cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activators. Prog Cell Cycle Res 2: 205–216.
   PubMedGoogle Scholar
• Thompson RL, Preston CM, Sawtell NM (2009). De novo synthesis of VP16 coordinates the exit from HSV latency in vivo. PLoS Pathog 5: e1000352.
   PubMed Web of Science ®Google Scholar
• Tsai LH, Delalle I, Caviness VS Jr, Chae T, Harlow E (1994). p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371: 419–423.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li H, Herrup K (2010). Cdk5 nuclear localization is p27-dependent in nerve cells: implications for cell cycle suppression and caspase-3 activation. J Biol Chem 285: 14052–14061.
   PubMed Web of Science ®Google Scholar